COVID-19前后骨质疏松症的识别与管理:远程会诊的兴起?
本文是一篇简短的综述,讨论在COVID-19大流行背景下,远程医疗在骨质疏松症管理中的应用证据。文章指出,骨质疏松门诊和骨折联络服务暂停后,医疗机构已转向电话或视频远程会诊;现有有限证据提示远程医疗方法可能为患者所接受,但关于其是否支持知情药物依从性、以及对听力、认知或视觉障碍和健康素养有限人群的适用性和获益,证据尚不明确。结论是迫切需要进一步的卫生服务评估和研究,以明确远程医疗对骨质疏松患者护理的影响及其可接受性和成本-临床效果。
要点
- COVID-19大流行促使骨质疏松诊疗转向电话或视频远程会诊。
- 有限证据提示远程医疗方法可能为骨质疏松患者所接受。
- 远程医疗是否支持知情药物依从性,证据尚不明确。
核心结论
- 迫切需要进一步的卫生服务评估和研究,以明确COVID-19期间远程医疗对患者护理的影响,并确定其对骨质疏松患者相关结局的可接受性、成本效果和临床效果。
研究设计与样本
- 本文为简短综述,讨论远程医疗在骨质疏松症管理中的证据。
主要发现
- 骨质疏松门诊和骨折联络服务暂停后,医疗机构已在人员允许时通过电话或视频提供新发和随访会诊的远程服务。
- 在不同疾病和背景下,关于远程医疗可接受性及其对医疗成本影响的证据尚不明确。
- 在骨质疏松管理背景下,有限证据提示远程医疗方法为患者所接受,但关于其是否支持知情药物依从性的证据不明确。
- 证据缺口涉及远程医疗在听力、认知或视觉障碍人群以及健康素养有限人群中使用的可接受性和获益。
临床怎么用
- 在COVID-19等导致门诊和骨折联络服务暂停的情况下,可考虑以电话或视频方式提供骨质疏松的新发和随访远程会诊。
- 应用远程医疗时需关注其对药物依从性的支持证据不明确,并注意听力、认知或视觉障碍及健康素养有限人群的证据缺口。
局限性
- 本文为简短综述,未提供原始研究数据或系统评价。
- 关于远程医疗可接受性、成本影响及对药物依从性支持的证据尚不明确。
- 在听力、认知或视觉障碍及健康素养有限人群中,远程医疗的可接受性和获益证据存在缺口。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: The COVID-19 pandemic is influencing methods of healthcare delivery. In this short review, we discuss the evidence for remote healthcare delivery in the context of osteoporosis. INTRODUCTION: The COVID-19 pandemic has undoubtedly had, and will continue to have, a significant impact on the lives of people living with, and at risk of, osteoporosis and those caring for them. With osteoporosis outpatient and Fracture Liaison Services on pause, healthcare organisations have already moved to delivering new and follow-up consultations remotely, where staffing permits, by telephone or video. METHODS: In this review, we consider different models of remote care delivery, the evidence for their use, and the possible implications of COVID-19 on osteoporosis services. RESULTS: Telemedicine is a global term used to describe any use of telecommunication systems to deliver healthcare from a distance and encompasses a range of different scenarios from remote clinical data transfer to remote clinician-patient interactions. Across a range of conditions and contexts, there remains unclear evidence on the acceptability of telemedicine and the effect on healthcare costs. Within the context of osteoporosis management, there is some limited evidence to suggest telemedicine approaches are acceptable to patients but unclear evidence on whether telemedicine approaches support informed drug adherence. Gaps in the evidence pertain to the acceptability and benefits of using telemedicine in populations with hearing, cognitive, or visual impairments and in those with limited health literacy. CONCLUSION: There is an urgent need for further health service evaluation and research to address the impact of remote healthcare delivery during COVID-19 outbreak on patient care, and in the longer term, to identify acceptability and cost- and clinical-effectiveness of remote care delivery on outcomes of relevance to people living with osteoporosis.
引用
- Paskins Z, Crawford-Manning F, Bullock L, et al. Identifying and managing osteoporosis before and after COVID-19: rise of the remote consultation? Osteoporos Int. 2020. PMID: 32548787. doi:10.1007/s00198-020-05465-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。